Center for Zoonotic and Emerging Infectious Diseases

人畜共患疾病和新出现的传染病对全球健康构成了日益严重和非常现实的威胁，由于人口密度不断增加，与家畜种群的接触增加，野生动物拥挤在人类经常接触的有限区域，因此我们必须扩大对这些疾病发病机制和预防的理解。为了满足对传染病研究能力的需求，在蒙大拿州立大学（MSU）建立了一个COBRE卓越中心，其目标是将蒙大拿州定位为人畜共患传染病发病机制研究的全国领导者。在过去四年中，该中心取得了极大的成功，发展了基础设施，招募和支持了初级调查员，并形成了一个有凝聚力的调查员中心。这些组成部分的协同作用为扩大本区域的传染病研究奠定了坚实的基础。有了这些基础设施，我们现在可以很好地扩展和加强中心，使其成为一个可扩展和可持续的研究企业。

Zoonotic and emerging infectious diseases represent an increasing and very real threat to global health, and it is essential that we expand our understanding of the pathogenesis and prevention of these diseases because of the increasing density of human populations, the increased exposure to domestic animal populations, and the crowding of wildlife into limited areas with frequent human contact. To address the need for infectious disease research capabilities, a COBRE Center of Excellence was established at Montana State University (MSU), with the goal of positioning Montana as a national leader in research on the pathogenesis of zoonotic infectious diseases. Over the past four years, the Center has been extremely successful, resulting in development of infrastructure, recruitment and support of junior investigators, and formation of a cohesive Center of investigators. The synergism of these components has resulted in the establishment of a solid foundation for expansion of infectious disease research in the region. With this infrastructure in place, we are now ideally poised to expand and strengthen the Center as a scalable and sustainable research enterprise. Our long term goal is to establish a sustainable Center of Excellence that is focused on understanding pathogenesis, host immune responses, and therapeutic development for zoonotic and emerging infectious diseases of regional and worldwide importance. While the foundation for this goal has been established through accomplishments realized during COBRE I, there is still a critical need for further faculty development, infrastructure enhancement, and recruitment of additional researchers in the area of zoonotic and emerging infectious diseases, and three specific aims are proposed to address these needs. First, we propose a pipeline to foster the development of current junior investigators so that funding and infrastructure resources are available at critical junctures in their careers. Secondly, we propose to increase the size, scope, and competitiveness of the Center through four new faculty hires. Together, accomplishment of these two aims will lead to establishment of the critical mass of investigators needed to sustain the Center and support future infectious disease research initiatives. Finally, we propose to strengthen the infectious disease research infrastructure in Montana through support and enhancement of established COBRE core facilities. Because of the success of COBRE I, the proven scientific abilities of the Center investigators, the outstanding institutional support, and the emphasis on a timely and increasingly important area of research, we believe that COBRE II support will lead to completion of a scalable and sustainable Center of Excellence in zoonotic and emerging infectious disease research.